Greenearth Biotechnologies Limited - Company Profile

It is a financial services public limited company based in Bangalore, Karnataka, India, established in 1991.
1991 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Greenearth Biotechnologies Limited

Greenearth Biotechnologies Limited, a active public limited company, was established on 30 September 1991 in Bangalore, Karnataka, India. Engaging in diversified financial services within the agriculture, forestry, fishing sector, it holds CIN: U85110KA1991PLC012371. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹3.60 M.

It upholds a compliant status. Its leadership includes Jagatbir Singh Sandhu (Director), Udayant Malhoutra (Director), Suresh Jayapal Naidu (Director). Past directors included Dodderi Srinivasayya Sathyanarayana, Milind Subhash Thakker, Suresh Jayapal Naidu. It holds no open charges and ₹2.48 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at No. 11 And 12, 5Th And 6Th Cross, 1St Stage Peenya Industrial Estate, Bangalore, Karnataka, 560058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110KA1991PLC012371

  • Registration Number

    012371

  • Incorporation Date

    30 September 1991

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹3.60 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 3.60 M
  • Company Age 34 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 2.48 Cr
  • Revenue Growth **** 872.92%
  • Profit Growth **** 65.76%
  • Ebitda **** 99.93%
  • Net Worth -0.06%
  • Total Assets -0.05%
Company report

Greenearth Biotechnologies Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Greenearth Biotechnologies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Greenearth Biotechnologies Limited?
Current Directors
Name Designation Appointment Date Status
Jagatbir Singh Sandhu Director 30 Sep 1991 Current
Udayant Malhoutra Director 30 Sep 1991 Current
Suresh Jayapal Naidu Director 07 Sep 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Sep 2015 Past
Pramod Abcsdd Director 19 Jun 2007 Past
Pramod Abcsdd Additional Director 29 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Greenearth Biotechnologies.

Greenearth Biotechnologies Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 872.92% increase. The company also saw a substantial improvement in profitability, with a 65.76% increase in profit. The company's net worth dipped by a decrease of 0.06%.

Greenearth Biotechnologies revenue growth over time
Greenearth Biotechnologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 872.92%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -0.05%
*******
*******
*******
*******
Profit or Loss
*******
 65.76%
*******
*******
*******
*******
Net Worth
*******
 -0.06%
*******
*******
*******
*******
EBITDA
*******
 99.93%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Greenearth Biotechnologies?

In 2022, Greenearth Biotechnologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹24,841,399.00

Charges Breakdown by Lending Institutions
  • Karnataka State Industrial Investment And Development Corpn Ltd : 1.12 Cr
  • Karantaka State Industrial Investment And Development Corp. : 0.84 Cr
  • Canara Bank : 0.47 Cr
  • Karnataka State Industrail Investment And Development Corp. : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
29 May 1998 Karnataka State Industrial Investment And Development Corpn Ltd ₹1.08 Cr Satisfied
09 Aug 1996 Canara Bank ₹2.70 M Satisfied
26 Jun 1995 Karnataka State Industrial Investment And Development Corpn Ltd ₹0.46 M Satisfied
28 Mar 1995 Karnataka State Industrail Investment And Development Corp. ₹0.50 M Satisfied
12 Sep 1994 Canara Bank ₹2.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Greenearth Biotechnologies?

Unlock and access historical data on people associated with Greenearth Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Greenearth Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greenearth Biotechnologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Greenearth Biotechnologies
Recent Activity within the Organization
  • Annual General Meeting

    Greenearth Biotechnologies Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Greenearth Biotechnologies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    Suresh Jayapal Naidu was appointed as a Director was appointed as a Director on 07 Sep 2015 & has been associated with this company since 10 years 6 months . was recorded as a recent event.

  • Charges

    Progress on A charge registered on 12 Sep 1994 via Charge ID 90191301 with Canara Bank was fully satisfied on 19 Jun 2013. was documented.

  • Charges

    Progress on A charge registered on 09 Aug 1996 via Charge ID 90189421 with Canara Bank was fully satisfied on 15 Jun 2012. was documented.

  • Charges

    A charge with Canara Bank of Rs. 0.20 Cr registered on 12 Sep 1994 with Charge ID 90191301 was modified on 28 Dec 2011. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Greenearth Biotechnologies Limited?

The CIN of Greenearth Biotechnologies Limited is U85110KA1991PLC012371.

Where is Greenearth Biotechnologies Limited headquartered?

Greenearth Biotechnologies Limited is headquartered at No. 11 And 12, 5Th And 6Th Cross, 1St Stage Peenya Industrial Estate, Bangalore, Karnataka, 560058.

When was Greenearth Biotechnologies Limited incorporated?

Greenearth Biotechnologies Limited was incorporated on 30 September 1991.

Who are the current directors of Greenearth Biotechnologies Limited?

The current directors of Greenearth Biotechnologies Limited are

What is the primary industry of Greenearth Biotechnologies Limited?

The primary industry of Greenearth Biotechnologies Limited is Agriculture, Forestry, Fishing.

Is Greenearth Biotechnologies Limited a listed company?

Greenearth Biotechnologies Limited is unlisted.

What is the capital structure of Greenearth Biotechnologies Limited?

The authorized capital of Greenearth Biotechnologies Limited is ₹1.00 Cr, and the paid-up capital is ₹3.60 M.

What is the compliance status of Greenearth Biotechnologies Limited?

The compliance status of Greenearth Biotechnologies Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available